We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+21.05%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.79B
AUM Growth
+$386M
(+27%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
6.74%
Top 10 Holdings %
Top 10 Hldgs %
33.84%
Holding
575
New
129
Increased
174
Reduced
152
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.2M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$39.6M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$10.5M |
| 4 |
L3Harris
LHX
|
+$4.57M |
| 5 |
Vanguard Small-Cap Value ETF
VBR
|
+$4.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$5.36M |
| 2 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$4.62M |
| 3 |
Gilead Sciences
GILD
|
+$4.55M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$4.16M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.8% |
| 2 | Healthcare | 8.12% |
| 3 | Financials | 4.94% |
| 4 | Communication Services | 4.63% |
| 5 | Consumer Discretionary | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Southern Company
SO
$109B
| $936K | 0.05% |
+18,049
| New | +$1M |
|
202
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
| $936K | 0.05% |
9,349
+448
| +5% | +$44.2K |
|
203
iShares US Real Estate ETF
IYR
$4.49B
| $929K | 0.05% |
11,792
-2,985
| -20% | -$226K |
|
204
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $913K | 0.05% |
33,042
+2,960
| +10% | +$79.3K |
|
205
Globant
GLOB
$1.32B
| $899K | 0.05% |
6,000
-4,000
| -40% | -$494K |
|
206
Norfolk Southern
NSC
$78.3B
| $882K | 0.05% |
5,021
+153
| +3% | +$25.9K |
|
207
Intuit
INTU
$77B
| $881K | 0.05% |
2,974
-13
| -0.4% | -$3.57K |
|
208
EOG Resources
EOG
$77.5B
| $874K | 0.05% |
+17,253
| New | +$836K |
|
209
Crane NXT
CXT
$3B
| $868K | 0.05% |
42,016
-10,955
| -21% | -$205K |
|
210
iRhythm Holdings
IRTC
$3.54B
| $866K | 0.05% |
7,472
-1,500
| -17% | -$165K |
|
211
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
| $846K | 0.05% |
17,782
+1,662
| +10% | +$74.2K |
|
212
Automatic Data Processing
ADP
$97.1B
| $836K | 0.05% |
5,618
+110
| +2% | +$15.8K |
|
213
iShares Core US Aggregate Bond ETF
AGG
$137B
| $833K | 0.05% |
7,044
-70
| -1% | -$8.2K |
|
214
AbbVie
ABBV
$454B
| $824K | 0.05% |
8,395
+798
| +11% | +$70.3K |
|
|
215
Gilead Sciences
GILD
$162B
| $823K | 0.05% |
10,693
-59,434
| -85% | -$4.55M |
|
216
Aurinia Pharmaceuticals
AUPH
$1.96B
| $813K | 0.05% |
+50,000
| New | +$801K |
|
217
iShares Core MSCI Total International Stock ETF
IXUS
$57.6B
| $808K | 0.05% |
14,825
+6,435
| +77% | +$331K |
|
218
Varonis Systems
VRNS
$5.14B
| $801K | 0.04% |
27,150
| – | – |
|
219
Logitech
LOGI
$14.8B
| $787K | 0.04% |
12,068
+699
| +6% | +$37.2K |
|
220
Mastercard
MA
$469B
| $772K | 0.04% |
2,610
+755
| +41% | +$213K |
|
221
Kura Oncology
KURA
$928M
| $760K | 0.04% |
46,634
-1,800
| -4% | -$26K |
|
222
Grupo Aval
AVAL
$5.86B
| $733K | 0.04% |
168,074
+103
| +0.1% | +$453 |
|
223
Morgan Stanley
MS
$338B
| $732K | 0.04% |
+15,161
| New | +$637K |
|
224
Nucor
NUE
$54.9B
| $707K | 0.04% |
+17,084
| New | +$690K |
|
225
Novartis
NVS
$297B
| $703K | 0.04% |
8,053
+3,102
| +63% | +$268K |
|
Similar funds
EC
SFM
NHC
EQF
NEI
MYIA
Bailard's Q2 2020 Portfolio in Review
As of Q2 2020, Bailard held 575 positions worth $1.79B, up 27% from $1.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Bailard deployed $121M of net new capital in Q2 2020, opening 129 new positions and adding to 174 existing holdings. Its largest new stake was L3Harris: 24,296 shares worth $4.12M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares S&P Small-Cap 600 Value ETF, an estimated $5.36M trimmed.
- Bailard's largest Q2 2020 buy was L3Harris: 24,296 shares worth $4.12M.
- Bailard added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $47.2M increase.
- Bailard's biggest Q2 2020 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $5.36M.
- Bailard fully exited Voyager Therapeutics in Q2 2020, selling an estimated $1.29M.
- Bailard's ten largest holdings make up 34% of its $1.79B portfolio in Q2 2020.
- Bailard opened 129 new positions and closed 75 in Q2 2020.
- Bailard's portfolio value rose 27% quarter-over-quarter to $1.79B.
Based on Bailard's 13F filing for Q2 2020, filed 12 Aug 2020.